The global Leukapheresis products market is projected to reach USD 98.5 Million by 2027 from USD 65.6 Million in 2022, at a CAGR of 8.5% between 2022 and 2027. The global Leukopaks market is projected to reach USD 784.2 Million by 2027 from USD 146.9 Million in 2022, at a CAGR of 39.8% between 2022 and 2027.
The market is mainly driven by factors such as the rising global cases of blood cancers, especially leukemia, growing applications of leukopaks in research, and rise in the number of blood donations globally. However, the high cost of therapeutic leukapheresis and leukopaks, stringent donor recruitment criteria, the dearth of skilled professionals, the low adoption of therapeutic leukapheresis, complications associated with therapeutic leukapheresis, the long procedural time for leukapheresis, the high cost of cellular immunotherapies, and a lack of favorable reimbursement are expected to restrain the growth of this market to a certain extent in the coming years.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=20283148
Market Growth Drivers
- Rising incidence and prevalence of leukemia
- Increasing number of blood donations
- Increased demand for leukopaks in clinical research
Market Growth Opportunities
- Leukapheresis for pediatric patients
- Emerging economies with investments from academic institutes, pharma-biotech companies, and leading players
- Gaps in current leukapheresis technologies
Market Challenges
- Blood transfusion safety in emerging countries
- Industry Trends
- Increasing Number of Collaborations Among Pharma and Biotech Companies
Key Technologies
- Centrifugal-based leukapheresis
- Membrane-based leukapheresis
The prominent players operating in the leukapheresis market are Asahi Kasei Corporation (Japan), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Terumo BCT, Inc. (US), Macopharma SA (France), and Miltenyi Biotec (Germany).
Some prominent players in the leukopaks market are Discovery Life Sciences (US), StemExpress, LLC (US), Charles River Laboratories International, Inc. (US), Caltag Medsystems Limited (UK), Lonza Group AG (Switzerland), and ZenBio (US)
Request 10% Customization:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=20283148
In this report, the overall Leukapheresis Market is divided into two sub-markets, the Leukapheresis Products Market and the Leukopaks Market. The Leukapheresis Products Market is classified into four segments—type, application, end user, and region, and the Leukopaks Market is classified into four segments—type, indication, end user, and region.
Disposables segment to dominate the leukapheresis products industry in 2021.
The disposables segment occupied a larger share of the Leukapheresis Products market in 2021, which can be attributed to the recurrent use of disposables during leukapheresis procedures, the increasing adoption of leukapheresis products for the collection of leukopaks and isolated PBMCs from leukopaks for research applications, and the increasing adoption of therapeutic leukapheresis procedures.
The mobilized leukopaks segment to occupy the largest share of the leukopaks industry in 2021.
The mobilized leukopaks segment accounted for the largest share of the leukopaks market in 2021. This can be attributed to a large number of mononuclear cells (MNCs) in these leukopaks compared to non-mobilized leukopaks, which increases their utility in research applications.
By end user, blood component providers & blood centers segment to hold the largest share of the leukapheresis products market.
The blood component providers & blood centers segment accounted for the largest share of the leukapheresis market in 2021. The increasing number of blood donations, the growing demand for leukopaks for the development of CAR T therapy, and the increasing demand for blood components in cancer research are expected to drive this segment during the forecast period.
“North America to occupy the largest share of the leukapheresis market in 2021
The Leukapheresis market is segmented into four major regions, namely, North America, Europe, Asia Pacific (APAC), and the Rest of the World.
North America accounted for the largest share of the Leukapheresis market in 2021. The strong presence of a large number of players and a large number of ongoing CAR T-cell therapy clinical trials are driving the growth of the leukapheresis market in the North American region.
Asia Pacific was the fastest growing region, which can be attributed to the growing number of personalized medicine, regenerative medicine, cell therapy research activities, and increasing funding for CAR T-cell therapy research.
Report Link: ( Leukapheresis Market & Leukopaks Market )
Recent Developments
- In July 2022, Discovery Life Sciences (US) acquired AllCells (US) to strengthen the portfolio for critical starting materials and analytic services to accelerate Competitive Generic Therapy (CGT) applications.
- In January 2021, Lonza Group AG (Switzerland) launched cryopreserved high-quality leukopaks to its product portfolio.
- In December 2021, Discovery Life Sciences, Inc. (US) acquired In Vitro ADMET Laboratories, LLC (US) to expand its product portfolio in drug research and development through the expansion of its biospecimen offerings.
- In January 2020, Fresenius Kabi inaugurated an expansion of its transfusion and apheresis disposables plant in the Dominican Republic in Santa Domingo.
Objectives of the Study
- To define, describe, and forecast the leukapheresis market by type, application, end user, and region
- To define, describe, and forecast the leukopaks market by type, indication, end user, and region
- To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To forecast the size of the leukapheresis products and leukopaks market with respect to four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To profile key players in the leukapheresis products and leukopaks market as well as comprehensively analyze their core competencies
- To track and analyze competitive developments such as product launches; acquisitions; expansions; as well as collaborations, agreements, and partnerships of the leading players in the overall leukapheresis (leukapheresis products and leukopaks) market
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/leukapheresis-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/leukapheresis.asp